Actively Recruiting
The Indiana Myeloma Registry
Led by Indiana University · Updated on 2025-11-10
2500
Participants Needed
1
Research Sites
523 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
CONDITIONS
Official Title
The Indiana Myeloma Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients 18 years of age or older at the time of informed consent
- Diagnosed with or suspected to have one of the following: Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Multiple Myeloma, Bony or Soft Tissue Plasmacytoma, Primary Amyloidosis
You will not qualify if you...
- Younger than 18 years of age
- Not diagnosed with or suspected to have Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Multiple Myeloma, Bony or Soft Tissue Plasmacytoma, or Primary Amyloidosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indiana University Simon Cancer Center
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
A
Attaya Suvannasankha, MD
CONTACT
N
Nisha George, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here